Blau Farmacêutica S.A. (BVMF:BLAU3)
Brazil flag Brazil · Delayed Price · Currency is BRL
8.78
+0.07 (0.80%)
Jul 29, 2026, 5:03 PM GMT-3

Blau Farmacêutica Financials Overview

Millions BRL. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,7641,7021,7541,3731,4071,366
Revenue Growth
-0.19%-2.96%27.81%-2.44%2.96%15.62%
Gross Profit
713.5682.74658.75490.25667.88665.93
Operating Income
329.11354.39328.8448.28452.19456.62
Net Income
243.79294.96217.21249.81363.37325.22
Earnings Per Share
1.051.280.941.081.571.39
EPS Growth
-8.75%35.80%-13.05%-31.18%12.69%12.33%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Retail+Aesthetics+Plasma
270268.99231.8619213197.85
Hospital
1,4941,4331,5231,1811,2761,269
Total
1,7641,7021,7541,3731,4071,366

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
542.18615.09492.87407.31643.65922.82
Total Debt
560.29599.13558.95608.54311.71374.52
Net Cash (Debt)
-18.115.95-66.08-201.22331.93548.3
Net Cash Growth
-----39.46%-
Net Cash Per Share
-0.080.07-0.29-0.871.442.35

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
276.63290.84507.2220.56171.9154.13
Capital Expenditures
-244.15-262.04-142.67-149.42-142.66-148.2
Free Cash Flow
32.4828.8364.5371.1429.245.93
Free Cash Flow Growth
-89.52%-92.10%412.43%143.26%392.80%-95.88%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
40.44%40.11%37.55%35.72%47.47%48.74%
Operating Margin
18.65%20.82%18.74%32.66%32.14%33.42%
Pretax Margin
18.47%22.82%16.64%24.35%33.30%35.31%
Profit Margin
13.82%17.33%12.38%18.20%25.83%23.80%
FCF Margin
1.84%1.69%20.78%5.18%2.08%0.43%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
0.355--0.2950.495
Dividend Per Share Growth
0%---40.40%-
Dividend Yield
4.04%--2.66%2.83%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
8.348.4610.7611.6712.8820.08
Forward PE
6.808.148.1312.6511.3615.20
P/FCF Ratio
62.4386.676.4140.99160.061100.43
PS Ratio
1.151.471.332.123.334.78